Crossmark

A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation

Crossref DOI link: https://doi.org/10.1038/s43856-024-00456-4

Published Online: 2024-03-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Robitaille, Karine

Guertin, Marie-Hélène

Jamshidi, Afshin

Xu, Hui Wen

Hovington, Hélène

Pelletier, Jean-François

Beaudoin, Lisanne

Gevariya, Nikunj

Lacombe, Louis http://orcid.org/0000-0003-4811-0308
Tiguert, Rabi

Caumartin, Yves

Dujardin, Thierry

Toren, Paul http://orcid.org/0000-0002-5762-5787
Lodde, Michele

Racine, Étienne

Trudel, Dominique

Perigny, Martine

Duchesne, Thierry http://orcid.org/0000-0001-9893-604X
Savard, Josée

Julien, Pierre

Fradet, Yves

Fradet, Vincent http://orcid.org/0000-0002-4714-1818
Funding

Funding for this research was provided by:

Canadian Cancer Society Research Institute (702569)

Philanthropic foundation of the CHU de Québec - Université Laval who founds different projects in its hospitals, including research projects.
License Information

Text and Data Mining valid from 2024-03-22

Version of Record valid from 2024-03-22
More Information

Article History

Received: 14 March 2023

Accepted: 7 February 2024

First Online: 22 March 2024

Competing interests

: The authors declare no competing interests. The study funders had no role on study design; collection, analysis, or interpretation of data; manuscript writing and decision to submit it for publication.

Document is current

Any future updates will be listed below